Middle East and Africa Pediatric Healthcare Market-Forecast To 2032

Middle East and Africa Pediatric Healthcare Market Research Report Information By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy and Immunology, Gastroenterology, Infectious Disease and Others), By Treatment (Medication, Surgery, and Others) And By Region (Middle East and Africa) –Market Forecast Till 2032

ID: MRFR/Pharma/2061-HCR | 72 Pages | Author: Kinjoll Dey | March 2024         

Pediatric Healthcare Market Speak to Analyst Request a Free Sample

Middle East and Africa Pediatric Healthcare Market Overview


Middle East and Africa Pediatric Healthcare Market Size was valued at USD 45.9 Billion in 2022. The Pediatric Healthcare market industry is projected to grow from USD 47.91 Billion in 2023 to USD 67.62 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.40% during the forecast period (2023 - 2032). Population grows, increasing costs for healthcare, expanding knowledge and instruction, technological progress, disease incidence, are the key market drivers enhancing the market growth.


Middle East and Africa Pediatric Healthcare Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Pediatric Healthcare Market Trends



  • Increasing changes in lifestyle is driving the market growth


The pediatric healthcare market in the Middle East and Africa (MEA) is a vibrant and quickly expanding industry that caters to the medical requirements of children in the area. It includes a wide range of medical services, such as screening, diagnosis, treatment, and specialised care for newborns, kids, and teenagers. Due to high birth rates and an expanding healthcare system, the MEA region has a sizable and growing population of youngsters. There is a considerable demand for pediatric healthcare services thanks to this expanding population. Governments in the area have been raising their healthcare spending to keep up with the rising demand because they understand how important it is to invest in healthcare, notably pediatric healthcare. The growing awareness and knowledge regarding children's heath is one of the major factors driving the MEA pediatric healthcare industry. Early childhood healthcare is important, and more and more parents and carers are seeking high-quality medical treatment for their kids. Due to the increase in demand for pediatric healthcare services, healthcare providers have been forced to expand their selections. Additionally, the development of the pediatric healthcare market in the MEA region has been significantly influenced by technological improvements. The diagnosis and treatment of pediatric disorders have been enhanced by new diagnostic techniques, cutting-edge medical procedures, and telemedicine options. These technology developments have boosted access to specialised care in far-flung and neglected locations while also improving healthcare results.


Pediatric health issues in the MEA region include chronic illnesses, malnutrition, and infectious diseases. The need for pediatric healthcare services has increased as a result of the incidence of these disorders. The region's governments have adopted a number of health-related measures, like as immunisation programmes and nutrition campaigns, which have helped the pediatric healthcare industry expand. The MEA pediatric healthcare market is expanding in large part due to medical tourism. For specialised pediatric treatments, nations like the UAE and South Africa have become major destinations for medical tourism. The expansion of pediatric healthcare facilities and services in these nations has been sparked by this influx of patients. Another important feature of the MEA pediatric healthcare industry is private sector participation. Private healthcare providers have made large investments in the area, enhancing healthcare infrastructure, providing cutting-edge therapies, and enhancing children's access to high-quality care. Thus, driving the Pediatric Healthcare market revenue.


Pediatric Healthcare Market Segment Insights


Pediatric Healthcare Type of Diseases Insights


The Middle East and Africa Pediatric Healthcare market segmentation, based on type of diseases includes short term diseases, chronic diseases and others. The short term diseases segment dominated the market, accounting for 41.2% of market revenue. Children are more likely than adults to contract short-term illnesses because of their immature immune systems and intimate social relationships in the community and at school.


Pediatric Healthcare Therapeutics Insights


The Middle East and Africa Pediatric Healthcare market segmentation, based on therapeutics, includes cardiology, allergy and immunology, gastroenterology, infectious disease and others. The infectious disease category generated the most income (37.2%). Pathogens like bacteria, viruses, fungi, and parasites are responsible for infectious diseases, which can harm a child's many organ systems.


Pediatric Healthcare Treatment Insights


The Middle East and Africa Pediatric Healthcare market segmentation, based on treatment includes medication, surgery and others. The medication segment dominated the market, accounting for 59.2% of market revenue. The administration of pharmacological medications to treat and manage pediatric diseases is a major component of pediatric healthcare.


Figure 1 Middle East and Africa Pediatric Healthcare Market, by Treatment, 2022 & 2032 (USD Billion)
Pediatric Healthcare Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Pediatric Healthcare Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The GCC Countries Pediatric Healthcare Market dominated this market in 2022 (45.80%). The development and expansion of pediatric healthcare services in the UAE is facilitated by the availability of specialised facilities, knowledgeable medical personnel, and a dedication to healthcare innovation.


Figure 2 MIDDLE EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET SHARE BY REGION 2022 (USD Billion)
Pediatric Healthcare Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


South Africa Pediatric Healthcare market accounts for the second-largest market share. This is due to the numerous top-notch hospitals and medical hubs in the area are outfitted with cutting-edge equipment and facilities to deliver complete pediatric healthcare services.


The Rest of MEA Pediatric Healthcare Market is expected to grow at the fastest CAGR from 2023 to 2032. Pediatric healthcare services are anticipated to advance due to initiatives to increase accessibility to healthcare, improve the healthcare staff, and use technology.


Pediatric Healthcare Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Pediatric Healthcare market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their Middle East and Africa footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Pediatric Healthcare industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Middle East and Africa Pediatric Healthcare industry to benefit clients and increase the market sector. In recent years, the Pediatric Healthcare industry has offered some of the most significant advantages to medicine. Major players in the Pediatric Healthcare market, including Novartis AG (Switzerland), AstraZeneca (UK), Janssen  Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE), and others, are attempting to increase market demand by investing in research and development operations.


Novartis AG, headquartered in Switzerland, is a major player in the Middle East and Africa (MEA) pediatric healthcare sector and a major worldwide pharmaceutical firm. Novartis focuses on creating cutting-edge medical treatments for a range of pediatric health issues. Novartis is dedicated to enhancing pediatric healthcare in the MEA region by providing a selection of medication made especially for kids. The business makes research and development investments to create secure and efficient solutions for pediatric illnesses. In order to improve access to pediatric healthcare and promote illness prevention and management, Novartis also works with healthcare providers, governments, and nonprofit organizations.


AstraZeneca, a leading pharmaceutical company headquartered in the UK. The company focuses on creating and offering cutting-edge drugs and therapies for a range of pediatric health issues. Across order to improve pediatric healthcare access and results, AstraZeneca collaborates with healthcare providers, governments, and non-profit organisations across the MEA area. The business makes investments in research and development to address the distinct healthcare requirements of children in the area, creating drugs and therapies that are suitable for pediatric patients and are both secure and efficient. The dedication of AstraZeneca to pediatric healthcare goes beyond drug development. In order to enhance pediatric health outcomes in the MEA region, the company actively supports collaborations, educational programmers, and campaigns that raise awareness of diseases. AstraZeneca aims to improve disease prevention, early diagnosis, and suitable treatment options for kids across the Middle East and Africa by collaborating closely with healthcare stakeholders.


Key Companies in the Pediatric Healthcare market include



  • Novartis AG (Switzerland)

  • AstraZeneca (UK)

  • Janssen Services

  • LLC (Belgium)

  • Eli Lilly and Company (US)

  • Bristol-Myers Squibb Company (US)

  • AMMT (Dubai)

  • King Faisal Specialist Hospital and Research Centre (Saudi Arabia)

  • VPS Healthcare (UAE)


Pediatric Healthcare Industry Developments


May 2018 Gilenya (fingolimod), manufactured by Novartis AG, is the first disease-modifying drug approved for the treatment of children and adolescents with relapsing forms of multiple sclerosis (RMS), according to the US Food and Drug Administration (FDA).


Pediatric Healthcare Market Segmentation


Pediatric Healthcare Type of Diseases Outlook



Pediatric Healthcare Therapeutics Outlook



Pediatric Healthcare Treatment Outlook



  • Medication

  • Surgery

  • Others

Report Scope:

Pediatric Healthcare Report Scope
Report Attribute/Metric Details
Market Size 2022 USD 45.9 Billion
Market Size 2023 USD 47.91 Billion
Market Size 2032 USD 67.62 Billion
Compound Annual Growth Rate (CAGR) 4.40% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type of Diseases, Therapeutics, Treatment, and Region
Geographies Covered Middle East and Africa
Countries Covered GCC Countries, South Africa and Rest of MEA
Key Companies Profiled Novartis AG (Switzerland), AstraZeneca (UK), Janssen  Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE)
Key Market Opportunities Partnerships and Alliance
Key Market Dynamics Concentrate on Immunisation and Disease Prevention




Frequently Asked Questions (FAQ) :

The Middle East and Africa Pediatric Healthcare market size was valued at USD 45.9 Billion in 2022.

The Middle East and Africa market is projected to grow at a CAGR of 4.40% during the forecast period, 2023-2032.

The key players in the market are Novartis AG (Switzerland), AstraZeneca (UK), Janssen  Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE).

The Infectious Disease category dominated the market in 2022.

The Medication had the largest share in the Middle East and Africa market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid